Keywords:
Blood glucose self-monitoring; Humans; Insulin pumps; Time in range; Type 1 diabetes
Abstract:
This prerandomization analysis from the Australian HCL-Adult trial (registration number: ACTRN12617000520336) compared masked continuous glucose monitoring (CGM) metrics among adults using insulin pumps versus multiple daily injections (MDIs), who were all self-monitoring blood glucose (SMBG).